Skip to Main content Skip to Navigation
New interface
Journal articles

2019 HRS expert consensus statement on evaluation, risk stratification, and management of arrhythmogenic cardiomyopathy

Jeffrey Towbin 1 William Mckenna 2 Dominic Abrams 3 Michael Ackerman 4 Hugh Calkins 5 Francisco C.C. Darrieux 6 James Daubert 7 Christian de Chillou 8, 9 Eugene Depasquale 10 Milind Desai 11 N.A. Mark Estes 12 Wei Hua 13 Julia Indik 14 Jodie Ingles 15 Cynthia James 5 Roy John 16 Daniel Judge 17 Roberto Keegan 18 Andrew Krahn 19 Mark Link 20 Frank Marcus 14 Christopher Mcleod 4 Luisa Mestroni 21 Silvia Priori 22 Jeffrey Saffitz 23 Shubhayan Sanatani 24 Wataru Shimizu 25 J. Peter van Tintelen 26, 27 Arthur A.M. Wilde 28, 26, 29 Wojciech Zareba 30 
Abstract : Arrhythmogenic cardiomyopathy (ACM) is an arrhythmogenic disorder of the myocardium not secondary to ischemic, hypertensive, or valvular heart disease. ACM incorporates a broad spectrum of genetic, systemic, infectious, and inflammatory disorders. This designation includes, but is not limited to, arrhythmogenic right/left ventricular cardiomyopathy, cardiac amyloidosis, sarcoidosis, Chagas disease, and left ventricular noncompaction. The ACM phenotype overlaps with other cardiomyopathies, particularly dilated cardiomyopathy with arrhythmia presentation that may be associated with ventricular dilatation and/or impaired systolic function. This expert consensus statement provides the clinician with guidance on evaluation and management of ACM and includes clinically relevant information on genetics and disease mechanisms. PICO questions were utilized to evaluate contemporary evidence and provide clinical guidance related to exercise in arrhythmogenic right ventricular cardiomyopathy. Recommendations were developed and approved by an expert writing group, after a systematic literature search with evidence tables, and discussion of their own clinical experience, to present the current knowledge in the field. Each recommendation is presented using the Class of Recommendation and Level of Evidence system formulated by the American College of Cardiology and the American Heart Association and is accompanied by references and explanatory text to provide essential context. The ongoing recognition of the genetic basis of ACM provides the opportunity to examine the diverse triggers and potential common pathway for the development of disease and arrhythmia.
Document type :
Journal articles
Complete list of metadata
Contributor : Christian de CHILLOU Connect in order to contact the contributor
Submitted on : Monday, April 26, 2021 - 6:41:02 PM
Last modification on : Friday, November 4, 2022 - 6:52:06 PM

Intranet access




Jeffrey Towbin, William Mckenna, Dominic Abrams, Michael Ackerman, Hugh Calkins, et al.. 2019 HRS expert consensus statement on evaluation, risk stratification, and management of arrhythmogenic cardiomyopathy. Heart Rhythm, 2019, 16 (11), pp.e301-e372. ⟨10.1016/j.hrthm.2019.05.007⟩. ⟨hal-03208773⟩



Record views